Related Experiment Video
Updated: May 5, 2026

Echocardiographic Assessment of the Right Heart in Mice
Published on: November 27, 2013
Hank the Heart and Animation-Based Education for Pulmonary Hypertension
Michelle Cash1, Barbara Giambra2,3,4,5, Lara Stone6
1Heart Institute, Cincinnati Children's Hospital Medical Center Cincinnati Ohio USA.
Abstract:
Pulmonary hypertension (PH) is a rare, complex disease affecting both children and adults. Efforts to provide health education are imperative as health literacy impacts patient and caregiver capacity to acquire, process, and understand health information and make informed health decisions. The current study sought to understand patient and family perception of "Hank the Heart", an animation used for enhancing health literacy, and preferred learning methods for future educational preferences. A qualitative study was conducted to assess the "Hank the Heart" animation using focus groups of family caregivers and patients. Focus group and interview transcripts underwent inductive thematic analysis. Patients and families have complicated health and educational needs that require a personalized approach, and they identified with the animated character as a representation of their reality. We identified three primary themes: (1) An animated video was found to be helpful but not sufficient to address all caregiver and patient educational needs, (2) Parents and children resonated strongly with elements of the video that represent their own experiences, and (3) Patient and family centered ongoing and tailored education is needed. The use of animation videos as a form of education was well received. Patient and family insights and suggestions were offered for improving future animation development.
More Related Videos
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Heart Failure II: Pathophysiology
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Cardiomyopathy III: Hypertrophic Cardiomyopathy

